Vaxart, Inc.
VXRT
$0.347
-$0.01-2.80%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 520.68% | 857.18% | 367.95% | 134.79% | 371.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 520.68% | 857.18% | 367.95% | 134.79% | 371.35% |
| Cost of Revenue | 184.53% | 61.70% | 54.06% | 0.43% | -7.09% |
| Gross Profit | 9.69% | 41.37% | 34.83% | 21.46% | 36.53% |
| SG&A Expenses | -11.18% | -29.99% | -26.05% | -11.77% | -7.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 139.81% | 36.42% | 32.42% | -2.58% | -7.19% |
| Operating Income | 10.17% | 37.95% | 32.00% | 18.78% | 29.48% |
| Income Before Tax | 8.99% | 36.42% | 31.35% | 19.00% | 27.01% |
| Income Tax Expenses | -4.76% | 111.11% | 1.15% | -53.85% | 10.53% |
| Earnings from Continuing Operations | 8.99% | 36.15% | 31.02% | 19.08% | 26.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.99% | 36.15% | 31.02% | 19.08% | 26.98% |
| EBIT | 10.17% | 37.95% | 32.00% | 18.78% | 29.48% |
| EBITDA | 11.66% | 42.05% | 36.47% | 22.25% | 32.77% |
| EPS Basic | 26.37% | 52.70% | 56.98% | 45.94% | 44.83% |
| Normalized Basic EPS | 26.26% | 52.88% | 57.26% | 45.94% | 44.90% |
| EPS Diluted | 26.37% | 52.70% | 56.98% | 45.94% | 44.83% |
| Normalized Diluted EPS | 26.26% | 52.88% | 57.26% | 45.94% | 44.90% |
| Average Basic Shares Outstanding | 23.64% | 35.02% | 60.44% | 49.61% | 32.31% |
| Average Diluted Shares Outstanding | 23.64% | 35.02% | 60.44% | 49.61% | 32.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |